ANI Pharmaceuticals, Inc. (ANIP) vs Eton Pharmaceuticals, Inc. (ETON)
- ANI Pharmaceuticals, Inc. ANIP 72.08 −0.28%
- Eton Pharmaceuticals, Inc. ETON 50.40 −1.81%
ANI Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.7B against $1.5B — 1.1× the size. ANI Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 107×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 81.5% against 30.9%. Eton Pharmaceuticals, Inc. has the higher net margin (12.0% vs 11.0%) and the higher return on invested capital (21.4% vs 11.3%). Across the 20 metrics below, ANI Pharmaceuticals, Inc. leads on 11 and Eton Pharmaceuticals, Inc. on 9.
Valuation
Profitability
| Metric | ANIP | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.40% | 57.87% | 53.94% |
| Operating margin | 15.37% | 15.44% | 0.00% |
| Net margin | 11.04% | 12.02% | 0.00% |
| Free cash flow margin | 17.12% | (7.94%) | 0.00% |
| Return on equity | 20.88% | 35.97% | (0.40%) |
| Return on assets | 7.61% | 11.67% | (3.32%) |
| Return on invested capital | 11.30% | 21.39% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack